Hewlett Packard Enterprise arrives at its June 1 earnings date with a striking split: short sellers have pulled back sharply from April's highs, yet the options market just flashed its most defensive reading of the year.
The short-interest picture tells a story of capitulation. Short interest peaked at 6.6% of free float on April 22 — a level that briefly sat among the highest readings of the past two months — and has since dropped to 5.1%, shedding roughly a quarter of those elevated positions in three weeks. The retreat maps neatly onto the stock's 21% one-month price gain, which closed at $30.21 on Tuesday. Shorts that built in the $24-$26 range were under meaningful pressure, and the unwind accelerated from late April into early May. Borrow conditions offer no sign of stress: cost to borrow is near-trivially cheap at 0.36% annualised, and availability is wide and loose. This is not a squeezed name — it's one where shorts are choosing to step aside.
Options positioning is a different conversation entirely. The put/call ratio surged to 0.87 on May 12, almost three standard deviations above its 20-day mean of 0.66. Every single session in the prior three weeks printed a PCR below 0.70; the jump to 0.87 is the highest defensive reading of the past year outside of a single day in late April. That is a sharp one-session shift, and it comes with the next earnings print just three weeks out. Investors are clearly paying up for downside hedges even as the underlying has rallied hard.
The Street is cautiously constructive but far from uniformly bullish. Most of the significant analyst moves date from March: BofA raised its target to $32 while reiterating Buy; Evercore lifted to $30, maintaining Outperform; Citi bumped to $27 with a Buy. Morgan Stanley kept its Equal-Weight stance and moved its target to $25 — well below where the stock now trades. The mean analyst target of roughly $27 sits about 11% below the current price, a configuration that typically reflects a stock that has moved faster than the Street's revisions. More recently, Raymond James downgraded in mid-April from Strong Buy to Outperform, trimming its target to $29 from $30. The valuation backdrop is undemanding: the stock trades at about 12x earnings on a P/E that has expanded roughly 2 points over the past month, with EV/EBITDA around 8.4x. Factor scores flag strong forward EPS growth estimates (94th percentile) and a high dividend score (92nd percentile), but near-term EPS momentum and surprise history sit in the bottom third of the universe.
The ownership picture has one notable blemish heading into the print. CEO Antonio Neri sold 150,000 shares at $26.50 on April 17, raising just under $4 million, and CFO Marie Myers followed on May 5 with a sale of 93,583 shares at $30. Combined, C-suite executives have been net sellers in both April and May. The insider net position over the past 90 days is actually positive — padded by director awards — but the open-market sales by the two most senior executives, both executed into strength, are worth noting in context of a stock approaching $30 for the first time in months.
Closest peer DELL rallied 10.5% on the week before selling off 3.3% on Tuesday, while NTAP and HPQ were softer. The group broadly gave back some of the week's gains on Tuesday, suggesting sector-level caution rather than a stock-specific HPE story. SMCI stood out, surging 18% on the week — a reminder of how wide AI-infrastructure sentiment can swing within the hardware peer group.
The June 1 print is now the focal point. The prior two results produced single-day moves of roughly flat to +3%, with five-day follow-through of +3-5% in each case. The sharp options shift into May 12 — from a cluster of calm PCR sessions to a sudden 0.87 spike — is the clearest signal that positioning is less settled than the retreating short interest alone would suggest.
See the live data behind this article on ORTEX.
Open HPE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
